SciNeuro Pharmaceuticals

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Astellas/Xyphos And GO Target Glycoprot

Roche Holding AG , Genentech, Inc. and their affiliated companies were the busiest deal makers in the biopharmaceutical sector for the second consecutive year in 2021, with 23 deals across all cate

Less than a year after its founding, Shanghai-based SciNeuro Pharmaceuticals is gearing up for a race to the clinical stage as Chinese bioventures revive their interest in central nervous system (CN

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gain, Zentalis Hope To Find Protein Mis